New Drug Delivery Systems Market And Top Key Players are 3M Company, Abbott Laboratories Ltd., Amgen Inc.

Novel Drug Delivery System (NDDS) involves the prompt and efficient provision of the prescribed or therapeutic amount of drug to the specific body site and also maintenance of the desired drug concentration. The drug must be delivered at a controlled rate customized for the particular body type and necessity over a specific period of treatment.

The fact that nearly 50% of the drugs developed lately cannot be taken orally, and an increased demand for drug efficacy and safety improvement has opened channels of innovation in this segment. There is also market scope for bio-recognition of drugs for disease-specific body sites and patient (or user) comfort level is also to be taken into consideration.

Market Survey reports suggest the global market for NDDS is expected to hit USD 320 billion by the year 2021, expanding at a CAGR of 2.7% from 2016 to 2022.

Download Sample of This Strategic Report:https://www.kennethresearch.com/sample-request-10065033

Technology

NDDS in cancer therapy market (major target market) is segmented into liquid embolic, embolization particles and nanoparticles. The largest revenue share in this market is set to be attained by the nanoparticles segment. The following are the advantages related with nanoparticles as opposed to traditional drug delivery system - 1) Protects the drug from degrading in the body before reaching the target area 2) Easy assessmentby oncologist about the drug's efficacy 3) Prevents interaction of the drug with regular cell thereby avoiding side effects.

Market Dynamics

There is huge scope for growth in the NDDS market owing to increasing incidences of various types of cancer, and its proficiency in overcoming the side effects of chemotherapy. Increasing prevalence of lifestyle induced diseases, chronic diseases, biologics market growth, new product launches, and drug innovation and technological advancements are market drivers of growth.

However, patent expiry and patent cliff, increasing injury incidences and side effects, high treatment cost and an authoritarian treatment pathway are anticipated to impede the market growth.A rise in government initiative by focus and implementation of 'Affordable Care Act' & 'Balanced Budget Act' is also a good sign.

The competition in the NDDS market is expected to intensify, with an ignition of price wars, and emphasis driving towards geographical expansion and penetration strategies to sustain in the market.

Market Segmentation

The NDDS market is segmented on the basis of route of administration, type of carrier and geographical region. The injectable drug delivery system had the largest market in 2015 followed by oral drug delivery system in terms of administration. It is efficient in the delivery of active drug substances with poor bio-availability and of those with a narrow therapeutic index. Liposomes and microspheres (carriers) together constitute the largest market share in terms of revenue (USD).

Geographic Analysis

North America is predicted to lead the global NDDS market owing to high disposable income, increasing related R&D activities, high adoption rate of novel technologies and supportive reimbursement policies, followed by Europe. However, the Asia Pacific region is bound to witness substantial growth in the future, especially, Japan, China, India, Australia and New Zealand owing to rising market penetration of NDDS in emerging economies.

Key Players

Some of the major players involved in the NDDS market are 3M Company, Abbott Laboratories Ltd., Amgen Inc., AstraZeneca Plc, Bausch & Lomb, Baxter International Inc., Bayer AG, Boehringer Ingelheim, Boston Scientific, Bristol-Myers Squibb, Celgene Corporation, Cephalon, Inc., Genentech Inc., Generex Biotechnology Corporation, Mannkind Corp., Genzyme Corporation, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Novartis AG, Pfizer Inc., Roche Holding AG, Sanofi SA, and Teva Pharmaceutical Industries Ltd.

Contact Us
David
Email: Sales@kennethresearch.com
Phone: +1 313 462 0609

About Kenneth Research:

Kenneth Research provides market research reports to different individuals, industries, associations and organizations with an aim of helping them to take prominent decisions. Our research library comprises of more than 10,000 research reports provided by more than 15 market research publishers across different industries. Our collection of market research solutions covers both macro level as well as micro level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides significant analysis on various markets with pure business intelligence and consulting services on different industries across the globe. In addition to that, our internal research team always keep a track on the international and domestic market for any economic changes impacting the products' demand, growth and opportunities for new and existing players.

This release was published on openPR.